Stock listing
Simcere Pharmaceutical Group Limited
Selected listing: S2P · FWB · EUR · DE
Simcere Pharmaceutical Group Limited (Frankfurt:S2P), Health Technology. Latest release Sep 1, 2026: Simcere Zaiming Enters Exclusive License Agreement…
- Ticker
- Frankfurt:S2P
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Frankfurt
- Currency
- EUR
About Simcere Pharmaceutical Group Limited
The company focuses on the development and commercialization of innovative pharmaceutical products. Simcere is committed to enhancing healthcare through its research and development efforts.
Latest news from Simcere Pharmaceutical Group Limited
Simcere Zaiming Enters Exclusive License Agreement with Roche for SIM0660 Global Development
September 1, 2026
Simcere Pharmaceutical Enters into a Research Collaboration Agreement with Stanford Medicine to Develop Innovative Therapies for Patients with Idiopathic Pulmonary Fibrosis
June 12, 2026
Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease
January 27, 2026
Simcere's IL-2 Mutant Fusion Protein SIM0278 Entered Phase II Clinical Trial Stage
November 10, 2025
NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase 1 Trial of SIM0505 (CDH6 ADC) into the United States
October 16, 2025
Research Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Limited company profile
View the public company page for Simcere Pharmaceutical Group Limited on 6ix.
Simcere Pharmaceutical Group Limited news
Read company news and market updates connected to Simcere Pharmaceutical Group Limited.
Simcere Pharmaceutical Group Limited investor events
Find investor webinars, events, and replay context for Simcere Pharmaceutical Group Limited.
Alternate listings
2096:HKEX
HK · HKD
Alternate listing for Simcere Pharmaceutical Group Limited; the primary context on this page is S2P:FWB.
SMHGF:OTC
US · USD
Alternate listing for Simcere Pharmaceutical Group Limited; the primary context on this page is S2P:FWB.
A2QD9S:LSX
DE · EUR
Alternate listing for Simcere Pharmaceutical Group Limited; the primary context on this page is S2P:FWB.
S2P:GETTEX
DE · EUR
Alternate listing for Simcere Pharmaceutical Group Limited; the primary context on this page is S2P:FWB.
S2P:TRADEGATE
DE · EUR
Alternate listing for Simcere Pharmaceutical Group Limited; the primary context on this page is S2P:FWB.
S2P:DUS
DE · EUR
Alternate listing for Simcere Pharmaceutical Group Limited; the primary context on this page is S2P:FWB.
S2P:MUN
DE · EUR
Alternate listing for Simcere Pharmaceutical Group Limited; the primary context on this page is S2P:FWB.
S2P:SWB
DE · EUR
Alternate listing for Simcere Pharmaceutical Group Limited; the primary context on this page is S2P:FWB.
A2QD9S:LS
DE · EUR
Alternate listing for Simcere Pharmaceutical Group Limited; the primary context on this page is S2P:FWB.